
Pexiol 0.75mg Tablet ER
Marketer
Ryon Pharma
Salt Composition
Pramipexole (0.75mg)
Overview Pexiol 0.75mg Tablet ER
Extended-release Pexiol 0.75mg tablets are indicated for managing Parkinson's disease and restless legs syndrome (characterized by an irresistible urge to move one's legs, often due to unpleasant sensations). This medication alleviates tremors by reducing motor activity. Administer Pexiol 0.75mg ER with food, consistently at the same time daily for optimal therapeutic blood levels. Follow your physician's prescribed dosage and duration; if a dose is missed, take it immediately upon recall. Complete the entire treatment regimen, even if symptoms improve, and avoid abrupt cessation without consulting your doctor. Potential adverse effects include nausea, xerostomia, lassitude, visual or auditory hallucinations, constipation, and peripheral swelling. Drowsiness and vertigo are also possible; refrain from operating machinery or engaging in activities demanding concentration until the drug's effects are known. Report any unusual shifts in mood, hypersexuality, compulsive gambling, or excessive spending to your doctor promptly, as these could be serious.
Primary Ingredients of Pexiol 0.75mg Tablet ER
No information provided. A rephrased version cannot be created.
Uses of Pexiol 0.75mg Tablet ER
Parkinson's disease and restless legs syndrome
Major Benefits of Pexiol 0.75mg Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. It's recommended to take the Pexiol 0.75mg Extended-Release Tablet with a meal.
Common Side effects of Pexiol 0.75mg Tablet ER:
- Dizziness
- Sleepiness
- Nausea
- Dryness in mouth
- Fatigue
- Hallucination
- Constipation
- Peripheral edema
- Muscle spasm
How to use Pexiol 0.75mg Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Pexiol 0.75mg Extended-Release Tablet should be administered with a meal.
How Pexiol 0.75mg Tablet ER works:
Pexiol 0.75mg Extended-Release tablets function by acting as a dopamine agonist, thereby regulating brain neurotransmission crucial for motor control.
SAFETY ADVICE
AlcoholUNSAFE
Extended-release Pexiol 0.75mg tablets can induce increased sleepiness when combined with alcohol.
PregnancyCONSULT YOUR DOCTOR
The extended-release Pexiol 0.75mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Pexiol 0.75mg tablet is likely unsuitable for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant. This medication's reduction of serum prolactin levels could negatively impact lactation.
DrivingUNSAFE
Extended-release Pexiol 0.75mg tablets can induce adverse reactions potentially impairing driving ability. These reactions may include hallucinations, causing perceptual distortions that could interfere with safe driving.
KidneyCAUTION
For individuals with impaired kidney function, the extended-release Pexiol 0.75mg tablet requires careful administration. Dosage modification of Pexiol 0.75mg extended-release tablets may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Extended-release Pexiol 0.75mg tablets are likely safe for individuals with hepatic impairment. Current evidence indicates dose modification may be unnecessary; however, physician consultation is advised.
What if you forget to take Pexiol 0.75mg Tablet ER :
Omit any missed dose of Pexiol 0.75mg Extended-Release Tablet and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Pexiol 0.75mg Tablet ER
| Label | Value |
|---|---|
| Chemical Category | Benzothiazole compound |
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
| Action Category | Dopamine-stimulating medications |
